1. Home
  2. HSTM vs PRME Comparison

HSTM vs PRME Comparison

Compare HSTM & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HealthStream Inc.

HSTM

HealthStream Inc.

HOLD

Current Price

$22.57

Market Cap

700.0M

Sector

Technology

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$2.98

Market Cap

666.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HSTM
PRME
Founded
1990
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
700.0M
666.1M
IPO Year
1999
2022

Fundamental Metrics

Financial Performance
Metric
HSTM
PRME
Price
$22.57
$2.98
Analyst Decision
Hold
Buy
Analyst Count
1
6
Target Price
$28.00
$7.56
AVG Volume (30 Days)
193.6K
2.0M
Earning Date
05-04-2026
05-08-2026
Dividend Yield
0.66%
N/A
EPS Growth
N/A
18.18
EPS
0.20
N/A
Revenue
$304,064,000.00
$4,632,000.00
Revenue This Year
$9.45
$7.06
Revenue Next Year
$5.12
$47.01
P/E Ratio
$113.77
N/A
Revenue Growth
4.26
55.28
52 Week Low
$19.50
$1.11
52 Week High
$29.59
$6.94

Technical Indicators

Market Signals
Indicator
HSTM
PRME
Relative Strength Index (RSI) 53.52 32.81
Support Level $21.19 N/A
Resistance Level $24.17 $3.97
Average True Range (ATR) 0.97 0.24
MACD 0.03 -0.05
Stochastic Oscillator 53.69 5.20

Price Performance

Historical Comparison
HSTM
PRME

About HSTM HealthStream Inc.

HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: